{
  "name": "Insilico Medicine",
  "slug": "insilico-medicine",
  "ticker": null,
  "fetched_at": "2025-12-26T12:24:15.626475+00:00",
  "news": [
    {
      "title": "AI drug designer Insilico Medicine aims to generate nearly $300M in Hong Kong IPO - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNQTBXWGJ1d2NtOFhFRDRucmJqeEI2NlRYLURocEluaUVnYV80bWFNWUpELWs2LTZ4ZmNiSlQwUWFEMVhEbEhCbGlKaGtUekF5T2xGMTBjMmw4RjlSQzdwaURYcFB6ZjRFZlFnUjdNdkZxOGlNU0psZnJzMTF2LUJYZjNqQ3pWTERmcGUtS2pJc2MxOTd6Zjg1dWJyZjNIRzU4VkU0TElUQjM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNQTBXWGJ1d2NtOFhFRDRucmJqeEI2NlRYLURocEluaUVnYV80bWFNWUpELWs2LTZ4ZmNiSlQwUWFEMVhEbEhCbGlKaGtUekF5T2xGMTBjMmw4RjlSQzdwaURYcFB6ZjRFZlFnUjdNdkZxOGlNU0psZnJzMTF2LUJYZjNqQ3pWTERmcGUtS2pJc2MxOTd6Zjg1dWJyZjNIRzU4VkU0TElUQjM?oc=5\" target=\"_blank\">AI drug designer Insilico Medicine aims to generate nearly $300M in Hong Kong IPO</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-12-18T08:00:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Insilico Medicine’s Pharma.AI Q4 Winter Launch Recap: Revolutionizing drug discovery with cutting-edge AI innovations, accelerating the path to pharmaceutical superintelligence - EurekAlert!",
      "link": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE1fQ3JoeTNfM0xQN3ZpX3hhcS1DTWY5U0RnQ2dtM3c0QnZOM1p1M01JcnFwVkRqejlrc1Q4QnVtblM1Rl9QeVZEZ004YnlFZXZ3eGtMVjIxN2haUnE0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1fQ3JoeTNfM0xQN3ZpX3hhcS1DTWY5U0RnQ2dtM3c0QnZOM1p1M01JcnFwVkRqejlrc1Q4QnVtblM1Rl9QeVZEZ004YnlFZXZ3eGtMVjIxN2haUnE0?oc=5\" target=\"_blank\">Insilico Medicine’s Pharma.AI Q4 Winter Launch Recap: Revolutionizing drug discovery with cutting-edge AI innovations, accelerating the path to pharmaceutical superintelligence</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">EurekAlert!</font>",
      "published": "2025-12-20T01:11:58+00:00",
      "source": "EurekAlert!"
    },
    {
      "title": "Insilico Medicine Is Said to Aim for Hong Kong Listing in Coming Weeks - Bloomberg.com",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQYlIzY19RcjEyZkdWeVNMNi1tWG1fNUJzU0xhOHJycndPUnZnMUFMNXo3WUt1bHlVNWR1RzM1QmltUV9aTkRjNFhOeFhYeHcwV28tYVJhMjVHQWRUTHo0ZVhkSG5lZGs0OG5aM2dlOThtbHBUa0ZZZmRxLU9QTUpXQjJvbnJ3MXo1Q0JiODFyNlBPUUlsSVJkNUN6MlRadU5EZjd4azhNTzRCZ01Sd1FrUWoxbUJJRnMzTHM5Tmh3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQYlIzY19RcjEyZkdWeVNMNi1tWG1fNUJzU0xhOHJycndPUnZnMUFMNXo3WUt1bHlVNWR1RzM1QmltUV9aTkRjNFhOeFhYeHcwV28tYVJhMjVHQWRUTHo0ZVhkSG5lZGs0OG5aM2dlOThtbHBUa0ZZZmRxLU9QTUpXQjJvbnJ3MXo1Q0JiODFyNlBPUUlsSVJkNUN6MlRadU5EZjd4azhNTzRCZ01Sd1FrUWoxbUJJRnMzTHM5Tmh3?oc=5\" target=\"_blank\">Insilico Medicine Is Said to Aim for Hong Kong Listing in Coming Weeks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg.com</font>",
      "published": "2025-12-09T08:00:00+00:00",
      "source": "Bloomberg.com"
    },
    {
      "title": "Lilly Expands AI Ties to Insilico, from Customer to Drug Discovery Partner - Genetic Engineering and Biotechnology News",
      "link": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQQzhpNS1FRnlhY0R1QlBCV0JJOHdKaEJFdE52NUlqazlyM1BfbUpUUlNVeXVOejEtcGZ4eGh1VkNuZmgxamI5S2NJNkM3R2tKMmRqM1hXcThwTjJhWl9SOGNuRmdPd3RYZjltNU9hWGJwUkl6TTA0OThDOTVxcHJPdFl1dGtjbmZ0bTFoN2Qyc01kT2NUMTRiRVBudzVRVGU5alhDeE5UWG5zd25yWGhhUkY1aXRPUV8xSmFPQmdoZUYzUXdYVzNxa1V2b1I?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizAFBVV95cUxQQzhpNS1FRnlhY0R1QlBCV0JJOHdKaEJFdE52NUlqazlyM1BfbUpUUlNVeXVOejEtcGZ4eGh1VkNuZmgxamI5S2NJNkM3R2tKMmRqM1hXcThwTjJhWl9SOGNuRmdPd3RYZjltNU9hWGJwUkl6TTA0OThDOTVxcHJPdFl1dGtjbmZ0bTFoN2Qyc01kT2NUMTRiRVBudzVRVGU5alhDeE5UWG5zd25yWGhhUkY1aXRPUV8xSmFPQmdoZUYzUXdYVzNxa1V2b1I?oc=5\" target=\"_blank\">Lilly Expands AI Ties to Insilico, from Customer to Drug Discovery Partner</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Genetic Engineering and Biotechnology News</font>",
      "published": "2025-11-10T08:00:00+00:00",
      "source": "Genetic Engineering and Biotechnology News"
    },
    {
      "title": "A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial - Nature",
      "link": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HdGtzRGJ6clRsZWc3b1RNRnNrdXZxRlpjUHF6OEdRanhiUXNkSjg3aWpsRFplOGdkRFZDNk1JMFk5RTd3UU5ONzd0Yi03ZjhWUWVTeXhnVHk1eWpHMnBJ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HdGtzRGJ6clRsZWc3b1RNRnNrdXZxRlpjUHF6OEdRanhiUXNkSjg3aWpsRFplOGdkRFZDNk1JMFk5RTd3UU5ONzd0Yi03ZjhWUWVTeXhnVHk1eWpHMnBJ?oc=5\" target=\"_blank\">A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nature</font>",
      "published": "2025-06-03T07:00:00+00:00",
      "source": "Nature"
    },
    {
      "title": "Inside FII9: Insilico Medicine - Entrepreneur",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNS08wUEpHS0RFb2x0UHZxU1l4TWx4NUhDOUN0cFE5Mk1aNFcwNG1sMGphOG9aaGRXZGZWTHFXTEdXbjNGc25HSUV1TUJWWW5xenA2U3ZGcFYweEpMRVU2WnVENzBWZVdCVmZjaTRrbElLYVRieTRxNnlaQkI1R1FPY3ZmbWtoV245akxWaTZsWGttVmtmMHc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxNS08wUEpHS0RFb2x0UHZxU1l4TWx4NUhDOUN0cFE5Mk1aNFcwNG1sMGphOG9aaGRXZGZWTHFXTEdXbjNGc25HSUV1TUJWWW5xenA2U3ZGcFYweEpMRVU2WnVENzBWZVdCVmZjaTRrbElLYVRieTRxNnlaQkI1R1FPY3ZmbWtoV245akxWaTZsWGttVmtmMHc?oc=5\" target=\"_blank\">Inside FII9: Insilico Medicine</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Entrepreneur</font>",
      "published": "2025-11-20T08:00:00+00:00",
      "source": "Entrepreneur"
    },
    {
      "title": "Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach - PR Newswire",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-06-03T07:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Insilico Medicine begins clinical trial for AI-designed cancer drug ISM3412 - News-Medical",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQMkVSLWxVMlMzLVlMT21ncHdsd3RjeVotRzdkZmlNV3R6R3pIaVkwRk9XLVp5ZnpvbDJ2ZmgyR1FLRjNPUGlacHBRZmFmSmNCWUd2bWZhV1JmTTh0dHZMQW5KSFU2NTlFM3J3b1RXcDhuQUpZYzBmTXo3dlozbWhmNEhreGhMNUI4UW02alVLdmE3RDMxSXpRUWJFMnZpQkt5Y01JekVmcXMtWGFwWllmS19vNUNreHhrRGNZRGJ6TjY?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQMkVSLWxVMlMzLVlMT21ncHdsd3RjeVotRzdkZmlNV3R6R3pIaVkwRk9XLVp5ZnpvbDJ2ZmgyR1FLRjNPUGlacHBRZmFmSmNCWUd2bWZhV1JmTTh0dHZMQW5KSFU2NTlFM3J3b1RXcDhuQUpZYzBmTXo3dlozbWhmNEhreGhMNUI4UW02alVLdmE3RDMxSXpRUWJFMnZpQkt5Y01JekVmcXMtWGFwWllmS19vNUNreHhrRGNZRGJ6TjY?oc=5\" target=\"_blank\">Insilico Medicine begins clinical trial for AI-designed cancer drug ISM3412</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">News-Medical</font>",
      "published": "2025-06-27T07:00:00+00:00",
      "source": "News-Medical"
    }
  ],
  "product_launches": [
    {
      "title": "Insilico Medicine’s Pharma.AI Q4 Winter Launch Recap: Revolutionizing drug discovery with cutting-edge AI innovations, accelerating the path to pharmaceutical superintelligence - EurekAlert!",
      "link": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE1fQ3JoeTNfM0xQN3ZpX3hhcS1DTWY5U0RnQ2dtM3c0QnZOM1p1M01JcnFwVkRqejlrc1Q4QnVtblM1Rl9QeVZEZ004YnlFZXZ3eGtMVjIxN2haUnE0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1fQ3JoeTNfM0xQN3ZpX3hhcS1DTWY5U0RnQ2dtM3c0QnZOM1p1M01JcnFwVkRqejlrc1Q4QnVtblM1Rl9QeVZEZ004YnlFZXZ3eGtMVjIxN2haUnE0?oc=5\" target=\"_blank\">Insilico Medicine’s Pharma.AI Q4 Winter Launch Recap: Revolutionizing drug discovery with cutting-edge AI innovations, accelerating the path to pharmaceutical superintelligence</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">EurekAlert!</font>",
      "published": "2025-12-20T01:11:58+00:00",
      "source": "EurekAlert!"
    },
    {
      "title": "InSilico Medicine Launches Hong Kong IPO - marketscreener.com",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQdm1KXzVnRndLVkhEeWs4UE13YmZNMWdELXFlLXNYT0JfMEdlYm0zQVFzNmlwMlVLNUE2UzJySlA3dU5sQlU1Mm5xZ2RrOE5TRG8tdTNUemJub1RNRjVEOFZhTHVjem9VVzhiU090LUstWUlMbzVyeHNwbTFrVHhMVkliNmI3a0NhSF80Q1V0OHlpcjZROEkyOQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxQdm1KXzVnRndLVkhEeWs4UE13YmZNMWdELXFlLXNYT0JfMEdlYm0zQVFzNmlwMlVLNUE2UzJySlA3dU5sQlU1Mm5xZ2RrOE5TRG8tdTNUemJub1RNRjVEOFZhTHVjem9VVzhiU090LUstWUlMbzVyeHNwbTFrVHhMVkliNmI3a0NhSF80Q1V0OHlpcjZROEkyOQ?oc=5\" target=\"_blank\">InSilico Medicine Launches Hong Kong IPO</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">marketscreener.com</font>",
      "published": "2025-12-18T02:02:15+00:00",
      "source": "marketscreener.com"
    },
    {
      "title": "Insilico Pharma.AI fall launch recap: Understand latest AI updates for healthcare research with frequent questions answered - EurekAlert!",
      "link": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE53VHVHSXcwdU1qUUhyVU1KUzVyMnkxbGxCRnVLT09yYnA5VE5pRWQ1emFNdnVVd1hoS09mQ0VDa3dOYWVfLVVJOGJ1OFRmcEMteTFYOXFIUkZlQVgt?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiXEFVX3lxTE53VHVHSXcwdU1qUUhyVU1KUzVyMnkxbGxCRnVLT09yYnA5VE5pRWQ1emFNdnVVd1hoS09mQ0VDa3dOYWVfLVVJOGJ1OFRmcEMteTFYOXFIUkZlQVgt?oc=5\" target=\"_blank\">Insilico Pharma.AI fall launch recap: Understand latest AI updates for healthcare research with frequent questions answered</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">EurekAlert!</font>",
      "published": "2025-10-21T07:00:00+00:00",
      "source": "EurekAlert!"
    },
    {
      "title": "North America AI in Pharma & Biotech Market Size, Share [2032] - Fortune Business Insights",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxONGh0ZUxRT3RUalR1LXl3ejlwc0FLWnNDZ3hsTEFhLU5Qa3l3VnB6Q1NheVRWN0pNZ0doS25GQUNyUTJfaEtEcmpsa0xIRlhuTGJNZmtJVFRycmVCQXVyT1ZWTXNXeFBqVUJ4c2l1TDhQV0tyTG5LRE5hRXh2MEhiTFRSaExPWG9WZWFpM0RSa2RTUQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxONGh0ZUxRT3RUalR1LXl3ejlwc0FLWnNDZ3hsTEFhLU5Qa3l3VnB6Q1NheVRWN0pNZ0doS25GQUNyUTJfaEtEcmpsa0xIRlhuTGJNZmtJVFRycmVCQXVyT1ZWTXNXeFBqVUJ4c2l1TDhQV0tyTG5LRE5hRXh2MEhiTFRSaExPWG9WZWFpM0RSa2RTUQ?oc=5\" target=\"_blank\">North America AI in Pharma & Biotech Market Size, Share [2032]</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fortune Business Insights</font>",
      "published": "2025-04-16T12:06:30+00:00",
      "source": "Fortune Business Insights"
    },
    {
      "title": "Menarini Group Licenses Preclinical Oncology Asset from Insilico Medicine - Contract Pharma",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVm96Wm5YSlIxNEZ2WVlZaDNKMk9LRjA0M1RneXR6NEQ2ZVh4bzN1TDZ2T2c3aTJrUktSTzExdE5JbmQ4RWs5empzQ0FEN1ExMnNNY0dZLUlOZVpuRUtRTVpCZTFyenh1XzAxYUUtQkJjX053YkppTjNuMVRMUUxfMWhNaTFVWEZ5NjZnNXdXdXQ0Y3NwVkVmUWN5YmdHZ0F1UnNUaVpvengyTG5tLXZnMXZzdUFXZF9uWVRJ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVm96Wm5YSlIxNEZ2WVlZaDNKMk9LRjA0M1RneXR6NEQ2ZVh4bzN1TDZ2T2c3aTJrUktSTzExdE5JbmQ4RWs5empzQ0FEN1ExMnNNY0dZLUlOZVpuRUtRTVpCZTFyenh1XzAxYUUtQkJjX053YkppTjNuMVRMUUxfMWhNaTFVWEZ5NjZnNXdXdXQ0Y3NwVkVmUWN5YmdHZ0F1UnNUaVpvengyTG5tLXZnMXZzdUFXZF9uWVRJ?oc=5\" target=\"_blank\">Menarini Group Licenses Preclinical Oncology Asset from Insilico Medicine</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Contract Pharma</font>",
      "published": "2025-01-10T08:00:00+00:00",
      "source": "Contract Pharma"
    }
  ],
  "stock": null
}